Traditional bacteriophage screening relies on manual isolation, empirical host-range plating, and fragmented bioinformatic scripts. PhageAI replaces empirical friction with standardized machine learning models—accelerating candidate selection from raw genomic reads with zero pipeline setup. systematically.
Direct, secure cloud ingestion of raw short-read or long-read sequencing data (Illumina, PacBio, Oxford Nanopore) and pre-annotated GenBank (.gbk) reference files. The platform automatically executes read-depth validation and rigorous QC integrity gates.
Proprietary machine learning and NLP models benchmark genomic profiles against 26,067+ curated phage genomes in under 60 minutes. The system flags lysogenic markers, latent prophages, and AMR determinants with 98% predictive accuracy.
Track genetic stability from Master Seed Lot down to Working Seed and Production Batches. Instantly export cryptographically verifiable Certificates of Analysis (CoA) structured to satisfy strict FDA 21 CFR Part 11 and GAMP 5 regulatory audits.
Join academic institutions, biotech teams, and GMP manufacturers benchmarking therapeutic candidates on PhageAI. Experience sub-60-minute turnaround and regulatory-ready reporting.